Evidence map›Paper›PMID 32655136›Full record

ArticleBone marrow transplantation2021

Chronic ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in Denmark - factors associated with risks and rates in adults according to conditioning regimen.

Helene Jeppesen, Henrik Sengeløv, Frank Eriksson, Jens Folke Kiilgaard, Susanne Tvede Andersen, Jens Lindegaard, Hanne Olsen Julian, Steffen Heegaard

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Helene JeppesenDepartment of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. helenejeppesen@gmail.com.ORCID http://orcid.org/0000-0001-7972-3698
Henrik SengeløvDepartment of Haematology, The Bone Marrow Transplantation Unit, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Frank ErikssonDepartment of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark.
Jens Folke KiilgaardDepartment of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-1054-1460
Susanne Tvede AndersenDepartment of Ophthalmology, Aabenraa Private Hospital, Copenhagen, Denmark.
Jens LindegaardCopenhagen Eye Infirmary, Copenhagen, Denmark.
Hanne Olsen JulianDepartment of Ophthalmology, Mølholm Private Hospital, Copenhagen, Denmark.
Steffen HeegaardDepartment of Ophthalmology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Copenhagen University Hospital · DKUniversity of Copenhagen · DK

Funding

Kræftens Bekæmpelse (Danish Cancer Society) R108-A7021-14-S31Novo Nordisk Fonden (Novo Nordisk Foundation) NNF15OC0014158
6 · The paper itself

Abstract

We investigated risks and hazard rates of developing chronic ocular graft-versus-host disease (oGVHD) in a large nationwide, single centre study by using the criteria proposed by "The International Chronic oGVHD Consensus Group". This retrospective study included 1407 consecutive adults who underwent allogeneic haematopoietic stem cell transplantation (HSCT). Patients were examined by an ophthalmologist according to the hospital's guidelines: baseline examination before HSCT, annually up to 5 years after HSCT. The 186 (13%) had dry eye disease before HSCT. The 5-year cumulative incidence of oGVHD was 18% (95% CI: 15-21) after myeloablative (MA) and 35% (95% CI: 30-39) after non-myeloablative conditioning (NMA). Factors associated with the rate of oGVHD were assessed separately according to conditioning regimen by using multiple Cox regression analyses. Factors that increased the rate in the MA group: Malignant disease, Schirmer's test≤10 mm/5 min before transplantation, use of female donor, matched unrelated donor, peripheral blood as stem cell source, and grade III-IV acute GVHD. Factors that increased the rate in the NMA group: Schirmer's test≤10 mm/5 min before transplantation and higher recipient age. We recommend a baseline ophthalmological examination before HSCT since many of the patients have signs of dry eyes before transplantation which increased the risk and rate of developing oGVHD.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAdultDenmarkFemaleHumansRetrospective StudiesTransplantation Conditioning

Identifiers

PMID32655136
OpenAlexW3042055595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.